Journal of Clinical Lipidology · Oct 29, 2026

Uncovering racial disparities in lipoprotein(a) testing utilization: A systematic review and meta-analysis

By Ghaseminejad-Raeini A, Razeghian I, Ghaderi A et al.

BACKGROUND: Lipoprotein(a) [Lp(a)] is a known cardiovascular risk factor recommended for routine clinical assessment. However, testing remains suboptimal across racial and ethnic groups. OBJECTIVE: This study evaluates disparities in Lp(a) testing patterns across various racial and ethnic groups and the underlying reasons. METHODS: A systematic review and meta-analysis of observational studies was conducted to compare Lp(a) testing rates among White, Black, and Asian populations using odds ratios (ORs) with 95% CIs calculated via the Mantel-Haenszel method, with heterogeneity assessed by the I² statistic. RESULTS: A total of 9 studies were included, resulting in a total study population of 22,683,125 individuals. The pooled Lp(a) testing proportion was 1.6% (95% CI: 0.8-2.7) (ranging from 0.3% to 4.9% across different studies). Among the general population visiting clinical care centers, Lp(a) testing was prescribed less in Black individuals (OR = 0.69 [95% CI: 0.47-1.01]) than in Whites. On the other hand, when probing established or high-risk cardiovascular disease (CVD) subjects, Asian individuals (OR = 1.89 [95% CI: 1.42-2.52]) were tested significantly more compared to Whites, whereas no significant differences were noted in Blacks. Meta-regression flagged history of stroke and statin use as the most probable sources of data heterogeneity. CONCLUSION: Although the importance of Lp(a) as a risk factor for CVD is recognized, screening remains suboptimal across different racial groups. This may be driven by clinician awareness gaps, cost barriers, inconsistent insurance coverage, and the absence of approved targeted therapies. Thus, providing education, broader insurance coverage, and establishing targeted therapies seem essential. PROSPERO REGISTRATION NUMBER: CRD420261436167.

doi.org/10.1016/j.jacl.2026.10.014PubMed 43052109Populations

AgingResearch.News